Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loade nanostructured lipid carriers
Tamoxifen (TAM) has been used in the treatment of breast cancers and is supplemented with erythropoietin (EPO) to alleviate the cancer-related anemia. The purported deleterious effects caused by the use of EPO with chemotherapeutic agents in the treatment of cancer-related anemia vary across studies...
Main Authors: | Beh, Chaw Yee, How, Chee Wun, Foo, Jhi Biau, Foong, Jia Ning, Selvarajah, Gayathri Thevi, Abdullah, Rasedee |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017
|
Online Access: | http://psasir.upm.edu.my/id/eprint/61455/1/Development%20of%20erythropoietin%20receptor-targeted.pdf |
Similar Items
-
Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system
by: Beh, Chaw Yee, et al.
Published: (2019) -
Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system.
by: Chaw Yee Beh, et al.
Published: (2019-01-01) -
Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers
by: Beh CY, et al.
Published: (2017-03-01) -
Zerumbone-loaded nanostructured lipid carrier induces apoptosis of canine mammary Adenocarcinoma cells
by: Foong, Jia Ning, et al.
Published: (2018) -
Effects of tamoxifen-loaded erythropoietin-coated nanostructured lipid carrier on breast cancer cells and rat mammary gland tumour
by: Beh, Chaw Yee
Published: (2019)